ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
25770.2 PFLS-LS
Project title
Development of a proprietary biomarker based companion diagnostic for identification and selection of cancer patients with disease driven by Notch pathway activation to be selected for treatment with Cellestia`s first-in-class pan NOTCH inhibitor and clinical development candidate drug CB-103.
Project status Finished
 
Start date 01.10.2017
End date 01.10.2019
 
Granted total costs 654'452.35  CHF
Section 20 Förderbereich Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % T490 Biotechnology
Last modification of the project